AE
Insider
Aron R. English
DirectorAron R. English (Director) filed 2 Form 4 reports in the past 24 months (1 purchase, 1 sale), most often in ANEB. Across 1 priced purchase filing, the average 21-session return was +48.1% from execution and +3.4% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of ANEB (10,101,010 sh × $0.99, as filed), executed Dec 23 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+48.1%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+3.4%
same 1 filings, from disclosure
Filings, ttm
2
1 buys · 1 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$19.1M
shares × price, as filed
Last traded
May 28 2025
Filed May 28 2025
Volume by month
Buys $10.0M
Sells $9.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
2 filings
Sector per market data · by filing · past 24 months
Most traded names
ANEB
ANEB
ANEB · 1 buy · 0 sells
1 filing
LFCR
LFCR
LFCR · 0 buys · 1 sell
1 filing
Recent filings
LFCRSALE
LIFECORE BIOMEDICAL, INC. \DE\
View filing →
$9.1M1,386,060 sh across 3 lots
Exec May 23 2025
Filed May 28 2025 · 5:30 PM ET ANEBPURCHASE Anebulo Pharmaceuticals, Inc. View filing → $10.0M
10,101,010 sh × $0.99
Exec Dec 23 2024
Filed Dec 26 2024 · 5:30 PM ET